78. Herbst, R.S., et al., Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Cli n Oncol, 2005. 23(24): p. 5578- 87.